学术探索
学术期刊
新闻热点
数据分析
智能评审

Update in diffuse Parenchymal lung diseases 2005

被引：15
作者：
Martinez, Fernando J.
Keane, Michael P.
机构：
[1] Univ Michigan, Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[2] Univ Calif Los Angeles, Div Pulm & Crit Care Med, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2006年 / 173卷 / 10期
关键词：
D O I：
10.1164/rccm.2601011
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：1066 / 1071
页数：6
相关论文
共 63 条
  • [1] Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
    Abdollahi, A
    Li, ML
    Ping, G
    Plathow, C
    Domhan, S
    Kiessling, F
    Lee, LB
    McMahon, G
    Gröne, HJ
    Lipson, KE
    Huber, PE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (06) : 925 - 935
  • [2] Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis
    Agostini, C
    Cabrelle, A
    Calabrese, F
    Bortoli, M
    Scquizzato, E
    Carraro, S
    Miorin, M
    Beghè, B
    Trentin, L
    Zambello, R
    Facco, M
    Semenzato, G
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (10) : 1290 - 1298
  • [3] Attenuation of bleomycin-induced pulmonary fibrosis by follistatin
    Aoki, F
    Kurabayashi, M
    Hasegawa, Y
    Kojima, I
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) : 713 - 720
  • [4] Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice
    Aono, Y
    Nishioka, Y
    Inayama, M
    Ugai, M
    Kishi, J
    Uehara, H
    Izumi, K
    Sone, S
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (11) : 1279 - 1285
  • [5] HRCT diagnosis of diffuse parenchymal lung disease: interobserver variation
    Aziz, ZA
    Wells, AU
    Hansell, DM
    Bain, GA
    Copley, SJ
    Desai, SR
    Ellis, SM
    Gleeson, FV
    Grubnic, S
    Nicholson, AG
    Padley, SPG
    Pointon, KS
    Reynolds, JH
    Robertson, RJH
    Rubens, MB
    [J]. THORAX, 2004, 59 (06) : 506 - 511
  • [6] Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
    Azuma, A
    Nukiwa, T
    Tsuboi, E
    Suga, M
    Abe, S
    Nakata, K
    Taguchi, Y
    Nagai, S
    Itoh, H
    Ohi, M
    Sato, A
    Kudoh, S
    Raghu, G
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (09) : 1040 - 1047
  • [7] TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis
    Bonniaud, P
    Margetts, PJ
    Ask, K
    Flanders, K
    Gauldie, J
    Kolb, M
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (08) : 5390 - 5395
  • [8] Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor
    Bonniaud, P
    Margetts, PJ
    Kolb, M
    Schroeder, JA
    Kapoun, AM
    Damm, D
    Murphy, A
    Chakravarty, S
    Dugar, S
    Higgins, L
    Protter, AA
    Gauldie, J
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) : 889 - 898
  • [9] ABCA3 mutations associated with pediatric interstitial lung disease
    Bullard, JE
    Wert, SE
    Whitsett, JA
    Dean, M
    Nogee, LM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) : 1026 - 1031
  • [10] CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling
    Burdick, MD
    Murray, LA
    Keane, MP
    Xue, YY
    Zisman, DA
    Belperio, JA
    Strieter, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (03) : 261 - 268
1234567